Share Prices & Company Research

Stockbroking

AstraZeneca

Current Price 6937.92p Bid 6814.00p Ask 6815.00p Change -1.02%
Last Updated: 16/10/2019 19:45. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

AstraZeneca plc is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Financial Highlights Year Ended 31/12/2018

Turnover
£22,090.00m
Operating Profit
£3,387.00m
Dividend Yield
3.18
Dividend Per Share
215.20
Dividend Cover
0.78
P/E Ratio
40.50

Key Personnel

Pascal Claude Roland Soriot
Chief Executive Officer
Marc Pierre Jean Dunoyer
Chief Financial Officer
Leif Valdemar Johansson
Non-Executive Chairman
Sherilyn Dawn McCoy
Non-Executive Director
Tony Shu Kam Mok
Non-Executive Director
Prof Sabera Nazneen Rahman
Non-Executive Director
Marcus Wallenberg
Non-Executive Director
Michel Roger Demaré
Non-Executive Director
Deborah DiSanzo
Non-Executive Director
Graham Andrew Chipchase
Non-Executive Director
Philip Arthur John Broadley
Non-Executive Director
Prof Geneviève Bernadette Berger
Non-Executive Director

Stock Details

EPIC
AZN
ISIN
GB0009895292
Shares in Issue
1,311,894,438
Market cap
£90,323.93m

Analyst Views (13)

Strong Buy
 
53.85%
Buy
 
0.00%
Hold
 
23.08%
Sell
 
7.69%
Strong Sell
 
15.38%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
6815.00p
Bid Price
6814.00p
Ask Price
6815.00p
Volume
1895735
Change Today
-70.00p
% Change Today
-1.02%
Open
6906.00p
Previous Close
6815.00p
Intraday High
7027.00p
Intraday Low
6770.00p
52 Week High
7583.00p
52 Week Low
5312.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

AstraZeneca Intra-day Chart

AstraZeneca News

News in this section is provided by AJ Bell

Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC 15 Oct 2019 | 09:20 UK stocks rally as fears over US economy ease 04 Oct 2019 | 16:43 FTSE holds gains ahead of US jobs data 04 Oct 2019 | 12:02 UK stocks open 0.3% higher; investors eye US jobs data 04 Oct 2019 | 09:05 AstraZeneca's respiratory drug gets regulatory nod in US for self-administration 04 Oct 2019 | 07:26 Investors spooked by US manufacturing shock 01 Oct 2019 | 16:37 UK stocks track sideways as Ferguson rallies; Greggs falls 01 Oct 2019 | 09:02 AstraZeneca sells rights to heartburn medication to Cheplapharm for up to $276m 01 Oct 2019 | 08:00 AstraZeneca gets hit with complete response letter from FDA for lung disease treatment 01 Oct 2019 | 07:54 UK stocks turn slightly lower at midday 30 Sep 2019 | 12:03 UK stocks edge higher as Brexit, trade tensions simmer 30 Sep 2019 | 09:11 AstraZeneca, Merck post positive study results for ovarian cancer treatment 30 Sep 2019 | 08:03 Airlines take off following Thomas Cook collapse 23 Sep 2019 | 16:42 FTSE falls as trade tensions linger and Thomas Cook collapses 23 Sep 2019 | 11:49 AstraZeneca sees Qtrilemt recommended for approval in EU 23 Sep 2019 | 07:19 FTSE treads water with Fed decision in focus 18 Sep 2019 | 11:58 UK stocks open slightly lower as investors await Fed rates decision 18 Sep 2019 | 08:53 AstraZeneca amends collaboration with Ironwood 18 Sep 2019 | 07:16 Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC 13 Sep 2019 | 10:10 Broker Forecast - Citigroup issues a broker note on AstraZeneca PLC 11 Sep 2019 | 08:10 Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC 09 Sep 2019 | 09:50 AstraZeneca says lung cancer treatment reduced death rates by 27% 09 Sep 2019 | 08:56 Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC 06 Sep 2019 | 12:40 AstraZeneca lung cancer treatment gets regulatory nod in China 04 Sep 2019 | 07:41 UK stocks hold on to gains at close 02 Sep 2019 | 16:22 UK stocks add to gains at midday 02 Sep 2019 | 11:50 UK stocks open 0.6% higher as Brexit drama intensifies 02 Sep 2019 | 09:03 Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC 02 Sep 2019 | 08:40 AstraZeneca diabetes drug combined with standard care shows reduction in heart failure 02 Sep 2019 | 07:28 AstraZeneca announces 'positive' results from clinical trial 02 Sep 2019 | 07:18

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
7,421.0
7,615.0
Intangible Assets & Goodwill
33,666.0
38,013.0
Investments & Other Non-Current Assets
3,973.0
4,576.0
Total Non-Current Assets
45,060.0
50,204.0
Inventory
2,890.0
3,035.0
Trade & Receivables
5,574.0
5,009.0
Cash & Receivables
4,831.0
3,324.0
Other Current Assets & Assets Held for Resale
2,296.0
1,782.0
Total Assets
60,651.0
63,354.0

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
16,292.0
16,383.0
Long Term Liabilities
30,315.0
30,329.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
46,607.0
46,712.0

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
14,044.0
16,642.0

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
317.0
317.0
Minority Interests
1,576.0
1,682.0
Retained Earnings
5,683.0
8,221.0
Share Premium Account
4,427.0
4,393.0
Other Equity
2,041.0
2,029.0
Total Equity
14,044.0
16,642.0

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
2,618.0
3,578.0
Cashflow Before Financing
3,581.0
1,250.0
Increase / Decrease in Cash
1,537.0
-1,686.0

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
22,090.0
22,465.0
Cost of Sales
4,936.0
4,318.0
Gross Profit
17,154.0
18,147.0
Operating Profit
3,387.0
3,677.0
Pre-Tax Profit
1,993.0
2,227.0
Profit / Loss for the Year
2,050.0
2,868.0

Dividend History

Data has been provided by AJ Bell

Period
Ex-Dividend Date
Payment Date
H1 Dividend
08 Aug 2019
09 Sep 2019
H2 Dividend
28 Feb 2019
27 Mar 2019
H1 Dividend
09 Aug 2018
10 Sep 2018
H2 Dividend
15 Feb 2018
19 Mar 2018
H1 Dividend
10 Aug 2017
11 Sep 2017
H2 Dividend
16 Feb 2017
20 Mar 2017
H1 Dividend
11 Aug 2016
12 Sep 2016
H2 Dividend
18 Feb 2016
21 Mar 2016
H1 Dividend
13 Aug 2015
14 Sep 2015
H2 Dividend
19 Feb 2015
23 Mar 2015
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.